Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
Clinical trial NCT02955771 · TERMINATED
Trial details
- NCT number
- NCT02955771
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2018-12-26
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.